Sulfacetamide Ophthalmic
Sulfacetamide ophthalmic is an antibiotic eye treatment used to treat conjunctivitis and other superficial eye infections, and as a support therapy for trachoma.
🧬 Where this information comes from Click to expand
The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 8 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →
📖 Sulfacetamide Ophthalmic: Patient Information Guide
A plain-language walkthrough of Sulfacetamide Ophthalmic — what it treats, how it works, how it’s taken, side effects, warnings and interactions. Tap any section to expand it.
🎯What it's used for▾
Sulfacetamide ophthalmic is an antibiotic used to treat bacterial infections on the surface of the eye. Supported uses include:
- Conjunctivitis (pink eye) caused by susceptible bacteria — treated with Sulfacetamide Sodium Ophthalmic Solution USP, 10%
- Other superficial ocular (eye surface) infections due to susceptible organisms, including Staphylococcus aureus, Streptococcus pneumoniae, Haemophilus influenzae, Klebsiella species, Enterobacter species, E. coli, and viridans group streptococci — Sulfacetamide Sodium Ophthalmic Solution USP, 10%
- Trachoma (a serious bacterial eye infection) — Sulfacetamide Sodium Ophthalmic Solution USP, 10% is used as an adjunct alongside systemic sulfonamide therapy; topical use alone is not sufficient
Note: this medication does not work against all bacteria. It does not adequately cover Neisseria species, Serratia marcescens, or Pseudomonas aeruginosa, and a significant portion of staph bacteria are fully resistant to sulfa drugs.
⚙️How it works▾
Sulfacetamide is a sulfonamide antibiotic. It works by competing with a substance called para-aminobenzoic acid (PABA) that bacteria need to make their own folic acid — an essential building block for growth. By blocking this step, sulfacetamide stops bacteria from multiplying, allowing the body's immune system to clear the infection.
It's worth knowing that not all bacteria are vulnerable to this mechanism. Some organisms — including certain staph strains and several gram-negative bacteria — are resistant or not adequately covered, which is why your prescriber selects this medication based on the likely cause of your infection.
💊How it's taken▾
Sulfacetamide Sodium Ophthalmic Solution is placed directly into the eye. For conjunctivitis and other superficial eye infections, it is typically used frequently at first — around every two to three hours — and then tapered (spaced further apart) as the infection improves. For trachoma, it is instilled every two hours and must always be used alongside a systemic antibiotic taken by mouth or injection. The usual treatment course is seven to ten days.
- Apply to the affected eye(s) only
- Follow your prescriber's schedule exactly — do not stop early even if the eye feels better
- This is for eye use only; never inject
🤒Side effects — in detail▾
Most people using sulfacetamide eye drops experience only minor local reactions. Common side effects include:
- Stinging or burning when the drops are applied
- Local eye irritation
- Eye redness (conjunctival hyperemia)
- Non-specific conjunctivitis (eye inflammation)
- Secondary infections
- Allergic reactions
More seriously, bacterial or fungal corneal ulcers (open sores on the eye surface) have developed during sulfonamide eye treatment. Rare but severe systemic reactions — including dangerous skin conditions and blood disorders — have also been reported (see warnings). Stop use and contact your doctor immediately if you notice a rash, blistering, unusual bruising, or any worsening symptoms.
⚠️Warnings & precautions▾
- Serious and potentially fatal reactions have occurred with sulfonamide drugs. These include Stevens-Johnson syndrome (a severe reaction affecting skin and mucous membranes), toxic epidermal necrolysis (widespread skin blistering), severe liver damage, and blood disorders including agranulocytosis and aplastic anemia. Although rare, these have been reported even with topical use.
- Stop using the drops at the first sign of a skin rash, blistering, or any other unexpected reaction, and seek medical attention right away.
- Sensitivity reactions can recur if you are re-exposed to a sulfonamide — even by a different route of administration. They can also occur in people with no previous history of sulfonamide allergy.
- This product is for eye use only — it must never be injected.
- Corneal ulcers (open sores on the eye surface) caused by bacteria or fungi have developed during treatment with sulfonamide eye preparations — report any new eye pain or vision changes promptly.
🔀What it interacts with▾
There is one key compatibility issue to be aware of with sulfacetamide eye drops:
- Silver-containing eye preparations: Sulfacetamide is chemically incompatible with silver preparations. Do not use these products together, as they can react and reduce effectiveness or cause irritation. Tell your doctor or pharmacist about all other eye drops or ointments you are using.
This is not a complete list of interactions. Always talk with your doctor or pharmacist before starting, stopping, or changing any medication.
📋Before taking it▾
- Sulfonamide allergy: Do not use this medication if you have had a hypersensitivity (allergic) reaction to any sulfonamide drug or to any ingredient in the preparation. This is a contraindication.
- Even if you have never reacted to a sulfonamide before, an allergic reaction is still possible — be alert for any new symptoms.
- If you have ever had a serious reaction to a sulfonamide in the past, sensitivity can return even with eye drop use — inform your prescriber.
- Tell your doctor about all other eye medications you are using before starting this treatment.
🔬Pharmacokinetics — how your body processes it▾
When sulfacetamide sodium is taken orally, it is readily absorbed from the gastrointestinal tract and excreted mostly unchanged in the urine. Its biological half-life (the time it takes the body to clear half the drug) has been reported to be between 7 and 13 hours. With topical application to skin, absorption is very low — studies with sulfacetamide sodium lotion found that only 0.08% to 0.33% of the applied dose was recovered in the urine. Eye drop use delivers the drug locally to the eye surface.
📦How to store it▾
Store between 2° to 25°C (36° to 77°F). Keep out of reach of children.
📄 Written from Sulfacetamide Ophthalmic’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Every point is grounded in that labeling — nothing is invented. How we use AI →
Supplements & herbs that interact with Sulfacetamide Ophthalmic
20 supplements and herbal products have documented interactions with Sulfacetamide Ophthalmic in the licensed clinical database we use. Most are manageable — but your pharmacist should know about everything you take, including vitamins and herbals.
- Moderate · 19
- Minor · 1
Educational information from a licensed clinical database (Natural Medicines) — see our data sources & update cadence. Not medical advice: an interaction being documented does not mean it will happen to you; do not start or stop medications or supplements without professional guidance.
🩺 Pharmacist Counseling Corner
Quick, plain-English answers to the questions patients ask most about Sulfacetamide Ophthalmic — the kind of thing our pharmacy team would talk through with you at the counter.
What is this eye drop actually treating? ▾
How often do I need to put the drops in? ▾
Is it normal for my eye to sting when I put the drops in? ▾
Are there any serious reactions I should know about? ▾
Can I use other eye drops at the same time? ▾
I've had an allergic reaction to a sulfa antibiotic tablet before — can I still use these drops? ▾
Is Sulfacetamide Ophthalmic available over the counter? ▾
When was Sulfacetamide Ophthalmic first available? ▾
Who makes Sulfacetamide Ophthalmic? ▾
💬 Answers drafted from Sulfacetamide Ophthalmic’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Grounded in that labeling — nothing is made up. How we use AI →
🧰 Keep exploring
💊 How Sulfacetamide Ophthalmic comes
Sulfacetamide Ophthalmic is available in 2 forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Eye drops
How this form is used
- Sulfacetamide Sodium Ophthalmic Solution USP, 10% is used to treat conjunctivitis and other superficial eye infections caused by susceptible bacteria
- Sulfacetamide Sodium Ophthalmic Solution USP, 10% is used alongside systemic sulfonamide therapy for trachoma
- Sulfacetamide Sodium: instill one or two drops into the conjunctival sac of the affected eye(s) every two to three hours initially for eye infections, then space doses out as the eye improves
- Sulfacetamide Sodium: for trachoma, instill two drops every two hours — systemic antibiotic therapy must be taken at the same time
- Sulfacetamide Sodium: the usual course of treatment is seven to ten days
- Sulfacetamide Sodium: for eye use only — never inject
Eye ointment
📊 Sulfacetamide Ophthalmic across the U.S. market
How Sulfacetamide Ophthalmic appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
📈 How widely Sulfacetamide Ophthalmic is used
A general measure of how commonly Sulfacetamide Ophthalmic is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.
Think of this as a proxy for how widely Sulfacetamide Ophthalmic is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.
How commonly is Sulfacetamide Ophthalmic prescribed? Of the 1,596 medications we measure, Sulfacetamide Ophthalmic ranks #902 by Medicaid prescriptions — more than 43% of them.
Utilization by Sulfacetamide Ophthalmic product
Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.
sulfacetamide sodium 100 MG/ML Ophthalmic Solution
Summed across the 1 of 12 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1006120
Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.
Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Sulfacetamide Ophthalmic, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 1 of 12 listed Sulfacetamide Ophthalmic NDCs with Medicaid activity.
🔍 Compare Sulfacetamide Ophthalmic products
A representative set of FDA-listed product records for Sulfacetamide Ophthalmic — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Eye drops | ||||
| 100 mg/mL | Ophthalmic | A-S Medication Solutions × 3 listings | ANDA | View NDC → |
| 100 mg/mL | Ophthalmic | Asclemed USA, Inc. × 2 listings | ANDA | View NDC → |
| 100 mg/mL | Ophthalmic | Bausch & Lomb Incorporated × 2 listings | ANDA | View NDC → |
| 100 mg/mL | Ophthalmic | Direct Rx | ANDA | Find on DailyMed ↗ |
| 100 mg/mL | Ophthalmic | NuCare Pharmaceuticals,Inc. × 2 listings | ANDA | View NDC → |
| 100 mg/mL | Ophthalmic | Pacific Pharma, Inc. | ANDA | Find on DailyMed ↗ |
| 100 mg/mL | Ophthalmic | Preferred Pharmaceuticals, Inc × 4 listings | ANDA | View NDC → |
| 100 mg/mL | Ophthalmic | Proficient Rx LP | ANDA | View NDC → |
| 100 mg/mL | Ophthalmic | RPK Pharmaceuticals, Inc. × 2 listings | ANDA | View NDC → |
| 100 mg/mL | Ophthalmic | Sandoz Inc. | ANDA | View NDC → |
| 💊Eye ointment | ||||
| 100 mg/g | Ophthalmic | Padagis US LLC | ANDA | View NDC → |
Showing 20 of 20 products — FDA National Drug Code Directory. See every product, package size and price: browse all 20 Sulfacetamide Ophthalmic NDCs →
📈 What people report — real-world data (FDA FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Sulfacetamide Ophthalmic — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Sulfacetamide Ophthalmic in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
🏛️ The road to your pharmacy
How Sulfacetamide Ophthalmic went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
🚨 Recall history
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
Source: openFDA drug enforcement (recall) reports.
RxNorm Concept Web — From Ingredient to Every Form and Strength
This page starts with one ingredient concept (IN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). Combination products remain separate concepts with their own pages.
RxCUI 10169 8 dose forms · 15 strengths
-
Dose form (SCDF) Medicated Liquid Soap RxCUI 544671No current FDA listingClinical drug / strength (SCD) sodium 100 MG/MLRxCUI 1006107 -
Dose form (SCDF) Medicated Shampoo RxCUI 702362No current FDA listing -
Dose form (SCDF) Ophthalmic Ointment RxCUI 378996In current FDA listingsClinical drug / strength (SCD) sodium 0.025 MG/MGRxCUI 1000868sodium 0.06 MG/MGRxCUI 1000874sodium 0.1 MG/MGRxCUI 1000673 -
Dose form (SCDF) Ophthalmic Solution RxCUI 377432In current FDA listingsClinical drug / strength (SCD) sodium 100 MG/MLRxCUI 1006120sodium 150 MG/MLRxCUI 1006710sodium 200 MG/MLRxCUI 1006727sodium 300 MG/MLRxCUI 1006729 -
Dose form (SCDF) Topical Cream RxCUI 451669No current FDA listingClinical drug / strength (SCD) sodium 100 MG/MLRxCUI 1006683 -
Dose form (SCDF) Topical Foam RxCUI 406196No current FDA listingClinical drug / strength (SCD) sodium 98 MG/MLRxCUI 1655061 -
Dose form (SCDF) Topical Gel RxCUI 451670No current FDA listingClinical drug / strength (SCD) sodium 0.1 MG/MGRxCUI 1000713 -
Dose form (SCDF) Topical Lotion RxCUI 377819No current FDA listing
Look up RxCUI 10169 in the RxCUI Atlas →
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
📦 Supply & shortage status
Whether Sulfacetamide Ophthalmic is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
🏷️ Sold under these brand names
🏭 Manufacturers & labelers
🔬 Where this comes from
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How we combine label and product data
HelloPharmacist combines public FDA and NLM records; we don’t author the underlying clinical facts. We identified 8 FDA-filed SPL label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. The representative label is the starting point for the displayed reference monograph; the 12 largest stored in-scope SPL records, which may include that representative, are compared section by section, and the longest available version of each section is retained. Forms, routes, brands, labelers, product-listed strengths, and product-record counts are aggregated separately from ingredient-matched FDA NDC Directory records; package records listed above are associated with the linked SPL; and the normalized concept hierarchy comes from NLM RxNorm.
Where a section is identified as AI-written, its plain-language text is generated from bounded label evidence. New draft drug pages remain in the admin review queue before first publication. Proficient Rx LP is the representative DailyMed label linked for verification and dates; it is not the sole source used for the page.
This is general education, not medical advice — always consult your doctor or pharmacist about your medications and any medical condition. For the exact wording of the linked representative label, view that label on DailyMed; some displayed composite sections may come from other in-scope SPL labels. Learn how we use AI and our data sources & update cadence.